g protein coupled receptor gpcr compound library (TargetMol)
Structured Review
G Protein Coupled Receptor Gpcr Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 91/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/position+module/GPCR+Compound+Library/pmc08227636-37-8-17
Average 91 stars, based on 6 article reviews
Images
Related Articles
other:Article Title: Identification of prostate cancer potential therapeutic targets and virtual drug screening through combined Mendelian randomization study, Bayesian colocalization and molecular docking. Article Snippet: S y n a p s e : s y n 5 1 3 6 4 9 4 3 Article Title: Computational Identification and Anti-Inflammatory Evaluation of T19093 as a TLR4/MD2 Inhibitor. Article Snippet: Background: The TLR4 (Toll-like receptor 4)/MD2 (Myeloid differentiation protein-2) is a crucial target for developing novel anti-inflammatory drugs.. Nevertheless, current inhibitors often have significant adverse effects, necessitating the discovery of safer alternatives.. Objective: The investigation aims to identify novel TLR4/MD2 inhibitors with potential antiinflammatory activity using machine learning and virtual screening technology. Article Title: Antimycin A inhibits alpha-herpesvirus replication by disrupting the formation of pyrimidinosomes. Article Snippet: The Article Title: Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2 C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell Tumors Article Snippet: A high-throughput drug sensitivity screen was performed using a compound library of 2,326 compounds and formulations composed primarily of FDA-approved pharmaceutical agents and agents targeting Article Title: Creating Chemiluminescence Signature Arrays Coupled with Machine Learning for Alzheimer’s Disease Serum Diagnosis Article Snippet: A Pierce albumin serum depletion kit was purchased from Thermo Fisher. Drug discovery:Article Title: Advancements in drug discovery: integrating CADD tools and drug repurposing for PD-1/PD-L1 axis inhibition Article Snippet: .. The key difference lies in the choice of compound library: High Throughput Screening Assay:Article Title: Ellipticine derivatives as Toll-like receptor 3 inhibitor for treating acute hepatitis. Article Snippet: Toll-like receptor 3 (TLR3) has been shown to influence various liver diseases.. By screening a natural product molecular library, we discovered that Ellipticine exhibits moderate TLR3 inhibitory effects, with an IC50 value of 5.66 ± 1.03 μM.. Subsequent optimization of Ellipticine led to the development of the most potent compound, SMU-14a, which achieved an IC50 of 0.18 ± 0.02 μM among all 31 derivatives. Screening:Article Title: Ellipticine derivatives as Toll-like receptor 3 inhibitor for treating acute hepatitis. Article Snippet: Toll-like receptor 3 (TLR3) has been shown to influence various liver diseases.. By screening a natural product molecular library, we discovered that Ellipticine exhibits moderate TLR3 inhibitory effects, with an IC50 value of 5.66 ± 1.03 μM.. Subsequent optimization of Ellipticine led to the development of the most potent compound, SMU-14a, which achieved an IC50 of 0.18 ± 0.02 μM among all 31 derivatives. |
